Bromelain is a natural enzyme found in pineapples that researchers are now looking at for managing various health problems. It has shown potential for conditions like cancer, cardiovascular disease, and metabolic disease. However, the current picture is not yet complete. Most of what we know comes from tests in test tubes and on animals. There is very limited evidence from actual human trials. This means we cannot yet say for sure how well it works in people or what the best dose should be. Safety for long-term use also remains unclear. While current data support bromelain as a promising helper in disease management, we need more well-designed studies. These future studies must focus on finding the right amount to take and checking for any long-term risks. Until then, patients should view this as an area of active research rather than a finished solution.
Bromelain shows promise for several diseases but needs more human testing
Photo by Navy Medicine / Unsplash
What this means for you:
Bromelain shows promise but needs more human trials to prove safety and effectiveness. More on Cancer
Narrative review of risk perception tools for chronic disease patients Your Health Worries Could Predict Your Future Disease Risk
Frontiers · May 8, 2026
Perspective review discusses chronic air pollution effects on children and older adults in Puerto Rico Air pollution may change your body’s microbes and raise cancer risk
Frontiers · May 1, 2026
Narrative review links ultra-processed food to obesity and multiple metabolic conditions Is Ultra-Processed Food Driving Obesity And Infertility
Frontiers · Apr 29, 2026
Systematic review finds first FDA-approved CRISPR therapy and broader clinical trial exploration First CRISPR gene therapy approved for blood disorders, with broader research underway
Frontiers · Apr 3, 2026